(Q39198639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Antonis Skliris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Vassiliki T Labropoulou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dionysios J Papachristou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alexios Aletras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Achilleas D Theocharis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

2342-2352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23387827%20AND%20SRC:MED&resulttype=core&format=json

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Glycosaminoglycans: key players in cancer cell biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin--structure and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Intracellular proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin: a structural and functional chameleon with wide impact on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin Is a Major Proteoglycan in Polarized Human Endothelial Cells and Is Implicated in the Secretion of the Chemokine GROα/CXCL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Extravasation and homing mechanisms in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Syndecans as receptors and organizers of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Hyaluronan-CD44 interactions as potential targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin is essential for maturation of mast cell secretory granule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Secretion of proteases in serglycin transfected Madin-Darby canine kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179

Nuclear localization of matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12179